Department of Anesthesia, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
BMC Anesthesiol. 2022 Sep 22;22(1):302. doi: 10.1186/s12871-022-01843-x.
When a difficult airway is unanticipatedly encountered and the initial laryngoscopic intubation fails, a supraglottic airway device (SAD) may be placed to aid ventilation and oxygenation, and act as a conduit for intubation. SaCoVLM™, as new SAD, can offer a direct vision to guide intubation. However, no study has evaluated the performance of SaCoVLM™ video laryngeal mask (VLM) intubation and i-gel combined with flexible bronchoscopy (FB)-guided intubation in airway management during general anesthesia.
A total of 120 adult patients were randomly allocated into the SaCoVLM™ group (Group S) and i-gel group (Group I). After induction of general anesthesia, guided tracheal intubation under direct vision of the SaCoVLM™ was conducted in Group S, while Group I received FB-guided tracheal intubation using the i-gel. The success rate of SAD placement, first-pass success rate of guided tracheal tube placement, and total success rate in both groups were recorded. The time for SAD placement, time for guided tracheal intubation, total intubation time (time for SAD placement and intubation), glottic exposure grading and postoperative intubation complications (i.e., dysphagia, hoarseness, pharyngalgia, etc.) of both groups were also compared.
The first-time success rate of SAD placement was 98% in two groups. The first-pass success rate of guided endotracheal intubation was 92% in Group S and 93% in Group I (P = 0.74 > 0.05). The total intubation time was 30.8(± 9.7) s and 57.4(± 16.6) s (95% CI = -31.5 to -21.7) in Group S and Group I, respectively (P < 0.01). The total complication rate was 8% in Group S and 22% in Group I (P < 0.05). The laryngeal inlet could be observed in the S group through the visual system of SaCoVLM™. No dysphagia or hoarseness was reported.
SaCoVLM™ can reveal the position of laryngeal inlet, thus providing direct vision for tracheal intubation. SaCoVLM™ -guided intubation is faster, and does not rely on FB, compared to i-gel combined with FB-guided intubation. Besides, SaCoVLM™ has a lower post-intubation complication rate.
Chinese Clinical Trials Registry (ChiCTR2100043443); Date of registration: 18/02/2021.
当遇到意外的困难气道且初次喉镜插管失败时,可放置声门上气道装置(SAD)以辅助通气和供氧,并作为插管的通道。SaCoVLM™作为新型 SAD,可提供直接可视性以引导插管。然而,尚无研究评估 SaCoVLM™视频喉镜(VLM)插管和 i-gel 联合纤维支气管镜(FB)引导插管在全身麻醉期间气道管理中的性能。
将 120 例成年患者随机分配至 SaCoVLM™ 组(S 组)和 i-gel 组(I 组)。在全身麻醉诱导后,S 组在 SaCoVLM™直视下进行引导气管插管,而 I 组则使用 i-gel 进行 FB 引导气管插管。记录 SAD 放置成功率、引导气管导管放置的首次成功率以及两组的总成功率。比较两组的 SAD 放置时间、引导气管插管时间、总插管时间(SAD 放置和插管时间)、声门显露分级和术后插管并发症(如吞咽困难、声音嘶哑、咽痛等)。
两组 SAD 放置的首次成功率均为 98%。S 组引导气管内插管的首次成功率为 92%,I 组为 93%(P=0.74>0.05)。S 组和 I 组的总插管时间分别为 30.8(±9.7)s 和 57.4(±16.6)s(95%CI=-31.5 至-21.7)(P<0.01)。S 组总并发症发生率为 8%,I 组为 22%(P<0.05)。S 组可通过 SaCoVLM™的可视系统观察到喉入口。无吞咽困难或声音嘶哑的报道。
SaCoVLM™可显露喉入口位置,从而为气管插管提供直接可视性。与 i-gel 联合 FB 引导插管相比,SaCoVLM™引导插管更快,且不依赖 FB。此外,SaCoVLM™的插管后并发症发生率较低。
中国临床试验注册中心(ChiCTR2100043443);注册日期:2021 年 2 月 18 日。